Molecular basis and clinical aspects of alfa 1 -antitripsin deficiency

1. Кравчук О.И.. Балановский О.П., Нурбаев С.Д. и др. Геногеография коренного населения Марий Эл (по данным об иммунобиологическом полиморфизме). Генетика 1998; 34: 1542-1554.

2. Кучер А.Н., Пузырев В.П., Иванова О.Ф. и др. Изучение субтипов сывороточных белков у русских жителей Томской области. Там же 1993; 29: 845-852.

3. Спицын В.А., Новорадовский А.Г., Спицына Н.Х., Парик Ю.Я. Полиморфизм а,-антитрипсина в популяциях Памира. Репродуктивная компенсация — возможный механизм поддержания генетического разнообразия популяций по генам Pi у человека. Там же 1989; 25: 2218-2224.

4. Спицын В.А., Макаров С.В., Пай Г.В. и др. Генетический полиморфизм и профессиональные заболевания: итоги 10-летних исследований. Вестн. РАМН 2000; 5: 27-32.

5. Терапия: Пер. с англ. М.: Гэотар медицина; 1997. 97, 311, 909.

6. Чучалин А.Г., Кронина J1.A., Воронина Л.М., Симилъчук Е.И. Случай сочетания муковисцидоза с дефицитом альфа-1-антитрипсина. Пульмонология 1994; 4 (3): 82-85.

7. Aboussouan L.S., Stoller J.K. New developments in α1-antitrypsin deficiency. Seminars Respir. Crit. Care Med. 1999; 20: 301-310.

8. α1-Antitrypsin deficiency: Memorandum from a WHO meeting. Bull. WHO. 1997; 75 (5): 397-415.

9. Beckman L., Sikstrom C., Mikelsaar A.-V. et al. α1-antitrypsin (Pi) alleles as markers of westeuropean influence in the Baltic Sea Region. Hum. Hered. 1999; 49: 52-55.

10. Blank C.A., Brantly M. Clinical features and molecular characteristics of α1-antitrypsin deficiency. Ann. Allergy 1994; 72: 105-122.

11. Blanko I., Fernandez E., Rodriguez M.C., Fernandez A. Allelic frequency of the gene of α1-antitrypsin in the general population in a county in Asturias. Med. Clin. (Bare.) 1999; 113: 266-270.

12. Boomsma D.I., Frants R.R., Bank R.A., Martin N.G. Protease inhibitor (Pi) locus, fertility and twinning. Hum. Genet. 1992; 89: 329-332.

13. Brantly М., Nukiwa Т., Crystal R.G. Molecular basis of Z α1-antitrypsin deficiency. Am. J. Med. 1988; 84 (suppl.6A): 13-31.

14. Browne R.J., Mannino D.M., Khoury M.J. α1-antitrypsin deficiency deaths in the United States from 1979-1991. An analysis using multiple-cause mortality data. Chest 1996; 110: 78-83.

15. Campbell E.J., Campbell M.A., Boukedes S.S., Owen C.A. Quantum proteolysis by neutrophils: implication for pulmonary emphysema in α1-antitrypsin deficiency. J. Clin. Invest. 1999; 104: 337-344.

16. Carrell R.W ., Lomas D.A., Sidhar S., Foreman R. α1-antitrypsin deficiency — a conformational disease. Chest 1996; 110: 243S-247S.

17. Cox. D.W. α1-Antitrypsin deficiency. In: Scriver C.R., Beaudet A.L., Sly W.S., Valle D., eds. The metabolic basis of inherited disease. 6th ed. New York: McGraw-Hill; 1989. 35.

18. Crystal R.G. The α1-antitrypsin gene and its deficiency states. Trends Genet. 1989; 5: 411-417.

19. Dry P.J. Rapid detection of «α1-antitrypsin deficiency by analysis of PCR-induced TaqI restriction site. Hum. Genet. 1991; 87: 742-744.

20. Eigenbrodt M.L., McCashland T.M., Dy R. M. et al. Heterozygous α1-antitrypsin phenotypes in patients with end stage liver disease. Am. J. Gastroenterol. 1997; 92: 602-607.

21. El-Kassimi F.A., Warsy A.S., Uz-Zaman A.A., Pillai D.K. α1-antitrypsin serum levels in widespread bronchiectasis. Respir. Med. 1989; 83: 119-121.

22. Elzouki A.N .Y., Segelmark М., Wieslander J., Eriksson S. Strong link between the α1-antitrypsin PiZ allele and Wegener's granulomatosis. J. Intern. Med. 1994; 236: 543-548.

23. Eriksson S.A. 30-year perspective on α1-antitrypsin deficiency. Chest 1996; 110 (suppl. P): 237S-242S.

24. Fonseca-Perez T., Gonzales-Coira M ., Arias S. Pi locus (α1-antitrypsin) allelic frequences in an Andean Venezuelan population. Gene Geogr. 1996; 10: 65-74.

25. Gadek J.E., Crystal R.G. «α1-Antitrypsin deficiency. In: Stanbury J.B., Wyngaarden J.B., Frederickson D.S. et al., eds. The metabolic basis of inherited disease. 5th ed. New York: McGrawHill; 1983. 1450-1467.

26. Graham A., Hayes K., Weidinger S. et al. Characterization of the «α1-antitrypsin M3 gene, a normal variant. Hum. Genet. 1990; 85: 381-382.

27. Higgins M.W., Thom T. Incidence, prevalence, and mortality: intra- and intercountry differences. In: Hensley M.J., Saunders M.A., eds. Clinical epidemiology of chronic obstructive pulmonary disease. New York: Marcel Dekker; 1989. 71.

28. Knight K.R., Burdon J.G., Cook L. et al. The proteinase-antiproteinase theory of emphysema: a speculative analysis of recent advances into the pathogenesis of emphysema. Respirology 1997-2: 91-95.

29. Kowalska A., Rujner J., Titenko-Holland N.V., Pilacik B. «α1-Antitrypsin subtypes in Polish newborns. Hum. Hered. 1995* 45: 351-354.

30. Larsson C. Natural history and life expectancy in severe α1- antitrypsin deficiency, PiZ. Acta Med. Scand. 1978; 204-345-351.

31. Lomas D.A., Carrell R.W. A protein structural approach to the solution of biological problems: «α1-antitrypsin as a recent example. Am. J. Physiol. 1993; 265: 211-219.

32. Lieberman J., Winter B., Sastre A. α1-Antitrypsin P-types in 965 COPD patients. Chest 1986; 89: 370-373.

33. Mahadeva R., Stewart S., Bilton D., Lomas D.A. α1-antitrypsin deficiency alleles and severe cystic fibrosis lung disease. Thorax 1998; 53: 1022-1024.

34. Morgan K., Scobie G., Kalsheker N.A. Point mutation in a 3-prime flanking sequence of the α1-antitrypsin gene associated with chronic respiratory disease occurs in a regulatory sequence. Hum. Mol. Genet. 1993; 2: 253-257.

35. Novoradovsky A., Brantly M .L., Waclawiw M .A. et al. Endothelial nitric oxide synthase as a potential susceptibility gene in the pathogenesis of emphysema in α1-antitrypsin deficiency. Am. J. Respir. Cell. Mol. Biol. 1999; 20: 441-447.

36. Nukiwa T., Brantly M.L., Ogushi F. et al. Characterization of the gene and protein of the common α1-antitrypsin normal M2 allele. Am. J. Hum. Genet. 1998; 43: 322-330.

37. O'brien M. L., Buist N. R., Murphey W.H. Neonatal screening for α1-antitrypsin deficiency. J. Pediatr. 1978; 92: 1006-1010.

38. Piitulainen E., Tornling G., Eriksson S. Environmental correlates of impaired lung function in non-smokers with severe «α1-antitrypsin deficiency (PiZZ). Thorax 1998; 53: 939-943.

39. Pittelkow M.R., Smith K.C., Su W.P.D. α1-Antitrypsin deficiency and panniculitis: perspectives on disease relationship and replacement therapy. Am. J. Med. 1988; 84: 80-86.

40. Poller W., Faber J.-P., Scholz S. et al. Mis-sence mutation of a,-antichymotrypsin gene associated with chronic lung disease. Lancet 1992; 339: 1538.

41. Propst T., Propst A., Dietze O. et al. High prevalence of viral infection in adults with homozygous and heterozygous α1-antitrypsin deficiency and chronic liver disease. Ann. Intern. Med. 1992; 117: 641-645.

42. Samilchuk E., D'Souza B., Voevodin A. et al. TaqI polymorphism in the 3'-flanking region of the Pi gene among Kuwaiti Arabs and Russians. Dis. Markers 1997; 13 (2): 87-92.

43. Sandford A.J., Weir T.D., Pare P.D. Genetic risk factors for chronic obstructive pulmonary disease. Eur. Respir. J. 1997; 10: 1380-1391.

44. Seersholm N., Kok-Jensen A., Dirksen A. Survival of patients with severe α1-antitrypsin deficiency with special reference to non-index cases. Thorax 1994; 49: 695-698.

45. Seersholm N., Kok-Jensen A., Dirksen A. Decline in FEV, among patients with severe hereditary aj-antitrypsin deficiency type PiZ. Am. J. Respir. Crit. Care Med. 1995; 152: 1922-1925.

46. Seersholm N.. Kok-Jensen A. Intermediate α1-antitrypsin deficiency PiSZ: a risk factor for pulmonary emphysema? Respir. Med. 1998; 92: 241-245.

47. Shin M .S., Ho K.-J. Bronchiectasis in patients with α1-antitrypsin deficiency: a rare occurrence? Chest 1993; 104: 1384-1386.

48. Silverman E.K., Miletich J.P., Pierce J.A. et al. α1-Antitrypsin deficiency: high prevalence in the St. Louis area determined by direct population screening. Am. Rev. Respir. Dis. 1989; 140: 961-966.

49. Silverman E.K., Pierce J.A., Province M.A. et al. Variability of pulmonary function in α1-antitrypsin deficiency: clinical correlates. Ann. Intern. Med. 1989; 111: 982-991.

50. Silverman E.K., Speizer F.E. Risk factors for the development of chronic obstructive pulmonary disease. Med. Clin. N. Am. 1996; 80: 501-522.

51. Spence W.C., Morris I.E., Pass K., Murphy P.D. Molecular confirmation of α1-antitrypsin genotypes in newborn dried blood specimens. Biochem. Med. Metab. Biol. 1993; 50: 233-240.

52. Stockley R.A. α1-Antitrypsin and the pathogenesis of emphysema. Lung 1987; 165: 61-77.

53. Stoller J.K., Smith P., Yang P., Spray J. Physical and social impact of α1-antitrypsin deficiency: results of a mail survey of the readership of a national newsletter. Cleveland Clin. J. Med. 1994; 61: 461-467.

54. Stoller J.K. Clinical features and natural history of severe α1-antitrypsin deficiency. Chest 1997; 111: 123S-128S.

55. Sveger T. Liver disease in α1-antitrypsin deficiency detected by screening of 200,000 infants. N. Engl. J. Med. 1976; 294: 1316-1321.

56. Sveger T. Prospective study of children with α1-antitrypsin deficiency: 8-year-old follow-up. J. Pediatr. 1984; 104: 91-94.

57. Titenko-Holland N.V., Kowalska A. α1-antitrypsin (Pi) subtypes in Russians and Poles. Hum. Hered. 1992; 42: 384-386.

58. Turino G.M., Barker A.F., Brantly M.L. et al. Clinical features of individuals with Pi*SZ phenotype of α1-antitrypsin deficiency. α1-antitrypsin Deficiency Registry Study Group. Am. J. Respir. Crit. Care Med. 1996; 154: 1718-1725.

59. Yang P., Wentzlaff K.A., Katzman J.A. et al. α1-antitrypsin deficiency allele carriers among lung cancer patients. Cancer Epidemiol., Biomarkers Prevent. 1999; 8: 461-465.

60. Zhou H., Fisher H.P. Liver carcinoma in PiZ oq-antitrypsin deficiency. Am. J. Surg. Pathol. 1998; 22: 742-748.